Wave Life Sciences Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Wave Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of $21.94. The average 1-year stock price forecast is 282.90% higher than the current stock price, while the lowest is $12 (+109.42%) and the highest is $43 (+650.44%).

Price Target: $21.94 (+282.90%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$12	$21.94	$18.5	$43
Change	+109.42%	+282.90%	+222.86%	+650.44%

Analyst Ratings

The average analyst rating for Wave Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	13	14	14	14	14	14
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	16	16	16	16	16

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Yun Zhong Wedbush	Wedbush	Buy Maintains $15	Buy	Maintains	$15	+161.78%	May 27, 2026
Whitney Ijem Canaccord Genuity	Canaccord Genuity	Buy Maintains $43	Buy	Maintains	$43	+650.44%	May 20, 2026
Benjamin Burnett Wells Fargo	Wells Fargo	Buy Reiterates $13 → $14	Buy	Reiterates	$13 → $14	+144.33%	May 20, 2026
Danielle Brill Truist Financial	Truist Financial	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 19, 2026
Steven Seedhouse Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $13	Buy	Maintains	$13	+126.88%	May 19, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

57.26M

from 42.73M

34.02%

from 42.73M

Revenue Next Year

51.52M

from 57.26M

-10.04%

from 57.26M

EPS This Year

-0.88

from -1.21

EPS Next Year

-1.11

from -0.88

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	40.96M	3.65M	113.31M	108.30M	42.73M	57.26M
Revenue Growth	104.03%	-91.09%	3,005.10%	-4.42%	-60.55%	34.02%
Gross Profit	-80.91M	-112.21M	-16.70M	-51.38M	-140.05M	57.26M
Gross Margin	-197.52%	-3,075.01%	-14.74%	-47.44%	-327.78%	100.00%
Operating Income	-127.02M	-162.72M	-68.00M	-110.40M	-215.38M	-237.57M
Net Income	-122.25M	-161.82M	-57.51M	-97.01M	-204.38M	-184.65M
EPS	-	-	-	-	-1.21	-0.88
Free Cash Flow	-78.24M	-67.01M	64.11M	-107.84M	-112.55M	-241.90M
No. Analysts	-	-	-	-	-	15

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	99.0M
Avg	57.3M
Low	38.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	131.7%
Avg	34.0%
Low	-11.1%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.88
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-